We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Benign Hematology

Journal Scan / Research · November 04, 2020

Turoctocog Alfa Is Safe for the Treatment of Indian Patients With Hemophilia A

Research and practice in thrombosis and haemostasis

 

Additional Info

Research and practice in thrombosis and haemostasis
Turoctocog Alfa Is Safe for the Treatment of Indian Patients With Hemophilia A: Guardian 10 Trial Results
Res Pract Thromb Haemost 2020 Oct 22;[EPub Ahead of Print], MJ John, P Chakrabarti, S Apte, M Bhattacharyya, Chandrakala S, T Hansen, R Kolla, C Ross, T Seth, N Siddharthan, A Abraham

Further Reading